Stenocare A/S
CSE:STENO
Stenocare A/S
Total Current Liabilities
Stenocare A/S
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
S
|
Stenocare A/S
CSE:STENO
|
Total Current Liabilities
kr11.1m
|
CAGR 3-Years
45%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Novo Nordisk A/S
CSE:NOVO B
|
Total Current Liabilities
kr208.4B
|
CAGR 3-Years
33%
|
CAGR 5-Years
27%
|
CAGR 10-Years
21%
|
||
H Lundbeck A/S
CSE:HLUN A
|
Total Current Liabilities
kr8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
ALK-Abello A/S
CSE:ALK B
|
Total Current Liabilities
kr1.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
Stenocare A/S
Glance View
Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.
See Also
What is Stenocare A/S's Total Current Liabilities?
Total Current Liabilities
11.1m
DKK
Based on the financial report for Dec 31, 2023, Stenocare A/S's Total Current Liabilities amounts to 11.1m DKK.
What is Stenocare A/S's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
55%
Over the last year, the Total Current Liabilities growth was 4%. The average annual Total Current Liabilities growth rates for Stenocare A/S have been 45% over the past three years , 55% over the past five years .